Martin Page
Before joining the Oncology-focused CRO (contract research organisation), Page was VP and head of global oncology research for J&J’S activities in Belgium and the US. He has also been at the forefront of several discovery teams looking at small molecule and MAb anti-cancer agents.
Page said: “I am extremely excited to work alongside the PRECOS team of expert scientists who are leading the way in providing robust models to enable testing of the next generation of oncology drug candidates.”